PIAS4 catalyzes FOXK2 SUMOylation at K527 and K633 (24, 43), facilitating nuclear translocation of FOXK2 and promoting de novo nucleotide synthesis, leading to hepatocellular carcinoma resistance against the chemotherapeutic drug 5-FU (24). This evidence concerns the gene PIAS4 and hepatocellular carcinoma.